ity and morbidity in these individuals. These metabolic alterNumerous investigations have demonstrated altered systemic ations include elevated carbohydrate utilization, enhanced lipid metabolism in cancer patients, as well as aberrant lipid utili-lipid and protein degradation, and reduced protein synthesis. zation by tumor cells. The most common measure of altered sys-Long-term metabolic alterations result in depleted fat stores, temic lipid metabolism in these individuals has been hyperlipid-decreased protein synthesis levels, increased carbohydrate emia. Although cachexia is not generally considered to be associ-metabolism, a general wasting of body tissues, and loss of ated with gynecologic cancers, this study demonstrates the body weight, which are collectively termed cachexia. The In studies evaluating the association of altered lipid metabthe ability of ascites-derived factors to induce HSL was examined. olism with tumor development and progression, the cancerThe addition of three of four ascites fluids increased the level of associated alterations in host intermediary metabolism were HSL in normal adipocytes. All of the patients' samples exhibited directed toward enhancing energy levels initially by the degelevated lipid levels versus normal peritoneal fluid. Isolation and radation of stored carbohydrates and later by mobilization analysis of lipids from three ovarian cancer patients revealed four of stored fats [1] [2] [3][4][5][6][7][8][9]. While altered lipid metabolism is exhibconsistent altered lipid parameters compared to normal peritoneal ited in many pathological conditions, the host lipid dysmefluid: elevated monoglycerides, diglycerides, and free fatty acids tabolism associated with neoplasia manifests unique characand decreased triacylglycerides. While ''classical'' cachexia is not teristics (such as whole body lipid levels, serum triglyceride a common feature of ovarian cancer, the presence of circulating levels, and the overall distribution of serum lipids), which lipolysis-promoting activity and altered lipid metabolism, generally observed in cachectic individuals, can be demonstrated in distinguishes it from other disease states [10][11][12]. Investigathese ovarian cancer patients. Based on recent evidence indicating tors have demonstrated severe loss of retroperitoneal fat a role of lipids in carcinogenic initiation or promotion, the presence stores, even in cases of noninvasive tumors without changes of tumor-derived lipolysis-promoting factor and lipid metabolism in nutrient intake, suggesting that tumors generate a lipolytic alterations may provide a mechanism for the epidemiologically substance, which is released into the circulation [4, 11, 13].
In studies evaluating the association of altered lipid metabthe ability of ascites-derived factors to induce HSL was examined. olism with tumor development and progression, the cancerThe addition of three of four ascites fluids increased the level of associated alterations in host intermediary metabolism were HSL in normal adipocytes. All of the patients' samples exhibited directed toward enhancing energy levels initially by the degelevated lipid levels versus normal peritoneal fluid. Isolation and radation of stored carbohydrates and later by mobilization analysis of lipids from three ovarian cancer patients revealed four of stored fats [1] [2] [3] [4] [5] [6] [7] [8] [9] . While altered lipid metabolism is exhibconsistent altered lipid parameters compared to normal peritoneal ited in many pathological conditions, the host lipid dysmefluid: elevated monoglycerides, diglycerides, and free fatty acids tabolism associated with neoplasia manifests unique characand decreased triacylglycerides. While ''classical'' cachexia is not teristics (such as whole body lipid levels, serum triglyceride a common feature of ovarian cancer, the presence of circulating levels, and the overall distribution of serum lipids), which lipolysis-promoting activity and altered lipid metabolism, generally observed in cachectic individuals, can be demonstrated in distinguishes it from other disease states [10] [11] [12] . Investigathese ovarian cancer patients. Based on recent evidence indicating tors have demonstrated severe loss of retroperitoneal fat a role of lipids in carcinogenic initiation or promotion, the presence stores, even in cases of noninvasive tumors without changes of tumor-derived lipolysis-promoting factor and lipid metabolism in nutrient intake, suggesting that tumors generate a lipolytic alterations may provide a mechanism for the epidemiologically substance, which is released into the circulation [4, 11, 13] . tion and have attributed the loss of body lipids to a circulating lipid-mobilizing factor [14] [15] [16] [17] [18] [19] [20] . The defects in lipid me-INTRODUCTION tabolism, as well as the circulating lipolysis-promoting activity, can be detected early in the progression of cancer and Cancer-associated cachexia is syndrome of weight loss, becomes more severe as the disease progresses [21] . Lipolyphysical decline, and early death. Progressive weight loss, sis-promoting activity has been demonstrated to be associdue to metabolic alterations, is a common finding among ated with many human and murine tumors, both in vitro and cancer patients and is the primary cause of increased mortal-in vivo and aberrant host lipid metabolism appears to be a direct consequence of released tumor-derived lipid mobilizing components [14] [15] [16] [17] [18] [19] [20] . The breakdown of stored lipids are commonly noted in ovarian cancer patients. Recent studies of ovarian cancers have enhanced our understanding, since many of the risk factors for these tumors (such as mine the lipolysis-promoting activity, test material was added to triplicate tubes in a total volume of 500 ml. The estrogen exposure, obesity, and diet) are associated with circulating lipids [26, 27] . Increasing evidence indicates that wells were incubated for 2 hr at 37ЊC and 100-ml aliquots were removed from each well. These aliquots were then dietary fat and subsequently, circulating fats may contribute to the development of hormone-related cancers, including assayed for glycerol concentrations using a commercial glycerol assay kit (Sigma Chemical Co.) based on the conversion ovarian and endometrial cancer [28] . Thus, indices of aberrant lipid metabolism may be useful markers for assessing of 2-(p-iodophenyl)-3-p-nitrophenyl-5-phenyltetrazolium chloride (INT) to INTH (formazan). Glycerol standards (0 these tumor types [29] .
While basic lipid changes have been described in cancer to 200 mM) were run in parallel with the test samples. For the radiometric bioassay, normal murine adipocytes were cachexia, this study provides a detailed, systematic characterization of altered lipid metabolism in ovarian cancer. This added to polystyrene tubes at a concentration of 10 6 cells per milliliter and incubated with [ 3 H]palmitic acid (1 mCi/ report investigates both the distribution of circulating lipids and the in vivo presence of lipolysis-promoting activity, ml) overnight. To determine the lipolysis-promoting activity, test material was added to triplicate tubes in a total volume which provides evidence for tumor-associated altered lipid metabolism in advanced ovarian cancer. of 500 ml. The wells were incubated for 2 hr at 37ЊC and 100-ml aliquots were removed from each well. These aliquots were then assayed for released To study the effects of patient-derived lipand Gynecology of the University of Louisville School of ids, the ascites fluid specimens were centrifuged at 100,000g Medicine, under a informed consent protocol approved by for 1 hr to remove cellular membranes and lipids were isothe University Human Studies Committee. The diagnoses lated from the supernatant. The supernatants were extracted of the patients included in this study are shown in Table by the modified procedure of Bligh and Dyer [30] . The lipid 1. Normal sera were obtained from non-tumor-bearing, suspension from each patient (or volunteer) was brought to healthy female volunteers and normal peritoneal fluid was a volume of 1 ml with 0.1 M formic acid with 1% NaCl and obtained from a woman undergoing abdominal surgery lipids were isolated by performing a two-step extraction with (noncancerous). chloroform:methanol:water. Initially, lipids were extracted Assay for lipolysis-promoting activity. The ability to with chloroform:methanol:water (1:2:0.8), and then chloropromote lipolysis was assayed either by a modification of the colorimetric bioassay described by Beutler et al. [16] 2 Abbreviations used: HSL, hormone-sensitive lipase; LP, lipolysis proor by a radiometric bioassay. In the modified colorimetric moting; LPF, lipolysis-promoting factor; PBS, 2-mM sodium phosphateprocedure, normal murine adipocytes were added to polysty-buffered saline, pH 7.4; PMSF, phenylmethylsulfonyl fluoride; TLC, thinlayer chromatography; TNF-a, tumor necrosis factor-a.
rene tubes at a concentration of 10 6 cells per tube. To deter-form:water was added to form a two-phase system (1:1:0.9). The lipids contained in the chloroform phase were concentrated in a rotary evaporator. Approximately 500 mg of extracted lipid from each sample was separated by thin-layer chromatography (TLC) using a silica gel G plate. The lipids were eluted with chloroform:methanol:water (1:1:0.2, v/v) and following separation, the lipid spots were visualized with iodine vapor. The spots corresponding to phospholipids, free fatty acids, and mono-, di-, and triglycerides (based on simultaneously run standards) were scraped from the plate and the groups were eluted and dried. The total fatty acid concentration was determined by gas chromatographic analysis following saponification. Each group was separated on a DuraBond 225 column using a Hewlett-Packard 5890 gas chromatograph. The fatty acids were separated using a standard temperature ramp of 165 to 226ЊC at 3ЊC/min.
Western blot analysis for hormone-sensitive lipase. Normal murine epididymal adipocytes were isolated and added three times with PBS. Cells were lysed in 1% NP-40, 500 mM NaCl, 50 mM Tris (pH 7.5), 1 mM DTT, and 1 mM PMSF. Protein concentrations were determined by the Bio-RESULTS Rad assay and were adjusted to identical concentrations.
Presence of serum-associated lipolysis-promoting activSolubilized proteins were separated by SDS-polyacrylity. In order to determine whether lipolysis-promoting acamide gel electrophoresis on a 10% acrylamide gel and transtivity could be detected in ovarian cancer patients, the level ferred onto Immobilon-P membranes by semidry electroblotof lipolysis induction produced by sera of patients with ovarting in transfer buffer (25 mM Tris, 190 mM glycine, and ian tumors was compared to that induced by sera from non-20% methanol). The blots were blocked with 5% nonfat dry tumor-bearing female volunteers. Figure 1 shows the level milk, 50 mM Tris (pH 7.5), 50 mM NaCl, 1 mM EDTA, of lipolysis induction, measuring the release of free glycerol and 1 mM DTT for 4 hr at 4ЊC, probed overnight at 4ЊC in from normal adipocytes in suspension, produced by these the same buffer with HSL-specific polyclonal antibody. serum samples from these ovarian cancer patients, described After this incubation, the membranes were washed three in Table 1 . Most patients exhibited a significant elevation times in 0.1% Tween 20 in PBS for 15 min at room temperaof circulating lipolysis induction (9/11) (compared to normal ture. The blots were then incubated in blocking buffer with controls), the presence of such activity in vivo suggests the anti-rabbit IgG conjugated with horseradish peroxidase for probability of aberrant systemic lipid metabolism. The levels 45 min at room temperature. These immunoblots were of lipolysis-promoting activity in the sera from normal (nonwashed again three times in 0.1% Tween 20 in PBS, after tumor-bearing) volunteers were not significantly different which bound complexes were visualized by enhanced chemi-from each other. These findings parallel previous studies in luminescence (ECL, Amersham Life Sciences, Arlington experimental animal tumor models, indicating that circulatHeights, IL). The resulting bands were compared to ing lipolysis-promoting activity could be detected in the cirprestained molecular weight standards run simultaneously culation of tumor-bearing animals, which developed to verify the appropriate molecular weight.
cachexia but not in animals bearing non-cachexia-inducing tumors [17, 20] . Statistical analysis of data. Quantitation of the levels of lipolysis-promoting activity was performed in quadruplicate
Association of lipolysis-promoting activity with ascites and differences in the levels were analyzed by Student's t fluids of ovarian cancer patients. The presence and level test. The levels of fat subgroups were determined in duplicate of lipolysis-promoting activity was further evaluated in the samples and figures presenting the fat levels and distribution ascites fluids of certain of these ovarian cancer patients. The level of lipolysis induction was assayed radiometrically and are the average of these results. and ascites samples), lipids were isolated from certain of these patients with advanced ovarian cancer, to determine if alterations in lipid metabolism were detectable in patients. The levels of lipids were elevated in the patients' ascites (versus noncancerous peritoneal fluid). The distributions of fats were determined for 500-mg aliquots of these samples following separation by TLC (Fig. 4) . There appeared to be  FIG. 2 . Lipolysis-promoting activity associated with ascites fluid sam-four consistent differences between patient-derived fats and ples from patients with ovarian cancer. Lipolysis promotion was assayed normal fluid-derived fats: mono-and diglycerides and free using murine adipocytes, which were labeled with [ 3 H]palmitic acid overfatty acids were elevated in patients with ovarian cancer night. These labeled cells were then treated with test samples for 2 hr and lipolysis was quantitated as free fatty acid ([ the monoglyceride fraction, patients exhibited an elevation of all fatty acids present. The diglyceride fraction of patientexpressed as counts per minute (cpm) released (Fig. 2) . Normal peritoneal fluid produced some lipid mobilization, perhaps due to the normal amalgamation of hormones and other physiologic factors. The level of ascites-associated lipolysispromoting activity was compared to the level in the normal fluid. The induction of lipolysis by patient samples was the amount of mobilization statistically above these background counts. The LP activity was significantly greater in all of the ascites fluid samples.
Induction of hormone-sensitive lipase by ascites-derived factor. Two mechanisms have been suggested for the hyperlipidemia associated with cancer patients: (1) suppression of lipoprotein lipase, as observed with TNF-a and (2) induction or activation of hormone sensitive lipase. Thompson et al. [31] demonstrated the amplification of HSL mRNA in the subcutaneous fat of cancer patients (versus noncancerous patients) and postulated this enhancement could account for observed hyperlipidemia. Since we have demonstrated the presence of lipolysis-promoting activity in both ascites fluids and sera of ovarian cancer patients, the ability of the ascites these patients expressed circulating LP activity (both in sera Fatty acid composition of triglyceride fractions of peritoneal fluid-derived fat determined by gas chromatography. After the TLC separafluid-derived fat determined by gas chromatography. After the TLC separation of patient-derived fats, the appropriate spot was removed, reextracted, tion of patient-derived fats, the appropriate spot was removed, reextracted, and further fractionation by gas chromatography as described under Materiand further fractionation by gas chromatography as described under Materials and Methods. Samples correspond to normal individual or patients de-als and Methods. scribed in Table 1 .
DISCUSSION
derived fats also exhibit a similar increased in all fatty acid types. The fatty acids 20:1 and 20:3 were present in patientderived fats, but were absent in normal fats. Examination of Recognizing that lipid metabolism is dramatically altered the triglyceride fraction revealed that all of the fatty acids in many cancer patients, particularly in terms of enhanced were reduced in patients versus control, except the fatty utilization and that these effects appear to be the direct conacids, 20:1, 20:3, and 22:6 were not significantly reduced in sequence of the tumor or tumor products, we have been patients. studying lipid metabolism associated with tumors. Changes in fuel utilization have been observed in cancer patients, with altered lipid utilization being the primary change [32] . The depletion of stored lipids can result from alterations in fat uptake, storage, biosynthesis and mobilization from adipocytes. The depletion of stored lipids in cancer patients appears to be a combination of decreased uptake of circulating triglycerides and increased lipolysis [33] . We have previously demonstrated that certain tumors express and release LPF [17, 19] and this factor can mobilize stored fatty acids from normal adipocytes, both in vitro and in vivo. Conditions producing lipid mobilization have been demonstrated to be associated with enhanced tumor growth [34] . Further evidence implicating lipid mobilization in enhancing tumor growth and in the development of cachexia has been that inhibition of lipolysis induction inhibited tumor growth [35] . Previous studies have indicated altered systemic lipid metabolism in cancer patients, with the most common marker being hyperlipidemia. In this study, we demonstrated the presence of lipolysis-promoting activity in the sera and asci -FIG. 6 . Fatty acid composition of diglyceride fractions of peritoneal tes of ovarian cancer patients. Elevated lipolysis-promoting fluid-derived fat determined by gas chromatography. After the TLC separa-activity was detectable in the sera of 7/9 patients and in the tion of patient-derived fats, the appropriate spot was removed, reextracted, ascites of 5/5 patients. While the significance of circulating and further fractionation by gas chromatography as described under Materials and Methods.
lipolysis-promoting activity has not been completely estab-
